<DOC>
	<DOCNO>NCT00565799</DOCNO>
	<brief_summary>PROTOCOL SUMMARY Type Study : Pilot , randomize single center trial Test Procedure : Omentectomy Aim 1 . Determine effect omentectomy 1 ) insulin sensitivity , 2 ) beta cell function 3 ) plasma marker inflammation We hypothesize removal omental fat increase insulin sensitivity pancreatic sensitivity glucose , decrease systemic inflammation . Aim 2 . Identify gene proteins adipocytes obese patient affect clinical presentation versus affect obesity future study . We hypothesize genetic sample help u identify gene protein adipocytes obese patient affect clinical presentation versus affect obesity help u design future obesity genetic study . Total Enrollment Number : 30 patient schedule undergo bariatric surgery weight loss New York University Medical Center invite participate study . Subjects randomly assign , use computer-generated randomization scheme , single-blind fashion either omentectomy ( n=15 ) control group ( n=15 ) .</brief_summary>
	<brief_title>A Pilot Study Metabolic Effects Omentectomy</brief_title>
	<detailed_description>Inclusion Criteria : - Patients consent undergo LAGB weight loss consent participate study - BMI ≥35 kg/m2 - Confirmed T2DM treat oral agent and/or diet therapy - Age 18-64 year Exclusion Criteria : - Insulin therapy - Weight change ( &gt; 2 % body weight ) within 4 week surgery - Patients T2DM 10 year Research Design- Pilot Study Event Week ( approximate ) Medical Screening ( conjunction routine pre-op visit ) -4 OGTT &amp; randomization -2 Preliminary genetic testing future study ( blood sample ) -2 Surgery without omentectomy 0 Preliminary genetic testing future study ( fat sample ) 0 Weight stabilization visit ( conjunction routine post-op visit ) 2 Weight stabilization visit ( conjunction routine post-op visit ) 4 OGTT 6 STUDY PLAN Study approve IRB , NYU School Medicine Committee , GCRC , Bellevue Hospital . Study initiation date : November 01 , 2007 Enrollment period : Nov. 2007 Nov. 2008 Study period : Nov. 2007 Jan 2008</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Patients consent undergo LAGB weight loss consent participate study BMI ≥35 kg/m2 Confirmed T2DM treat oral agent and/or diet therapy Age 1864 year Insulin therapy Weight change ( &gt; 2 % body weight ) within 4 week surgery Patients T2DM 10 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>DM</keyword>
</DOC>